Picture EBD Group Global Partnering Four Events One Price 650x80

Document › Details

DiaSorin S.p.A.. (5/8/18). "Press Release: The DiaSorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018". Saluggia.

	Organisation	DiaSorin S.p.A. (FTSE Italia Mid Cap: DIA)
	Group	DiaSorin (Group)
	Organisation 2	Siemens (Group)
	Product	Liaison MDX system
	Product 2	ELISA assay (diagnostics) (enzyme linked immunosorbent assay)
	Index term	DiaSorin–Siemens: ELISA immunoassays, 201707– acquisition up to €47.5m of Siemens ELISA Dx portfolio/assets without employees + mftg capacity
	Person	Fava, Riccardo (DiaSorin 201607 IR + Corporate Communications Director)
	Person 2	Di Terlizzi, Ines (DiaSorin 201607 Investor Relations)

Original document
accessed by [iito] on 2018-05-08

Record changed: 2018-05-09

More documents for DiaSorin (Group)

[1] DiaSorin S.p.A.. (4/11/21). "Press Release: DiaSorin to Acquire Luminex Corporation for USD 37.00 per Share or Approximately USD 1.8 Billion". Saluggia....
[2] Qiagen N.V.. (11/27/19). "Press Release: Qiagen and DiaSorin Receive FDA Approval for the Liaison QuantiFERON-TB Gold Plus Test on Liaison Platforms and Begin Commercial Launch". Germantown, MD, Hilden & Saluggia....
[3] Qiagen N.V.. (6/5/19). "Press Release: Qiagen and DiaSorin Collaborate on Novel QuantiFERON-based Test with Breakthrough Potential for Earlier Detection of Lyme Disease". Germantown, MD, Hilden & Saluggia....
[4] Qiagen N.V.. (9/17/18). "Press Release: Qiagen and DiaSorin Launch Automated Testing for Latent TB Infection with QuantiFERON-TB Gold Plus Technology on Widely Used Liaison Platforms". Hilden & Saluggia....
[5] DiaSorin S.p.A.. (12/12/17). "Press Release: DiaSorin Launches a New Simplexa Bordetella Direct Molecular Test". Saluggia....
[6] DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia....
[7] DiaSorin S.p.A.. (8/3/17). "Press Relase: DiaSorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017". Saluggia....
[8] DiaSorin S.p.A.. (7/25/17). "Press Release: DiaSorin to Acquire ELISA Immunodiagnostic Business Portfolio and Associated Assets from Siemens Healthineers". Saluggia....
[9] DiaSorin S.p.A.. (7/10/17). "Press Release: DiaSorin Launces Iam CBFB-MYH11, Completing the Diagnostic Test Menu for Molecular Screening of Acute Myeloid Leukemia by Q-LAMP". Saluggia....
[10] Tecan Group Ltd.. (6/23/17). "Press Release: DiaSorin and Tecan to Collaborate in New Platform Development". Saluggia & Männedorf....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]